Open AccessLevothyroxine/Liothyronine Combination Therapy and Quality of Life: Is It All about Weight Loss?
Author(s) -
Luba Freja Michaelsson,
Jeppe Lerche la Cour,
Bjarke Borregaard Medici,
Torquil Watt,
Jens Faber,
Birte Nygaard
Publication year - 2018
Publication title -
european thyroid journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.23
H-Index - 10
eISSN - 2235-0802
pISSN - 2235-0640
DOI - 10.1159/000490383
Subject(s) - medicine , levothyroxine , weight loss , quality of life (healthcare) , combination therapy , thyroid function , cohort , pediatrics , weight gain , thyroid function tests , thyroid , endocrinology , body weight , obesity , nursing
According to one hypothesis, the popularity of levothyroxine (L-T 4 )/liothyronine (L-T 3 ) combination therapy relates to weight loss. The purpose of this study was to detect a possible correlation between thyroid-related quality of life (QoL) and weight loss in hypothyroid patients switched from L-T 4 monotherapy to L-T 4 /L-T 3 combination therapy.